Medical specialists from Austria tagged as investigators in clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell
Total 13 results
-
August Zabernigg, MDSeen in:
- Kufstein, A.ö. Bezirkskrankenhaus Kufstein, Innere Medizin / Hämatologie / Onkologie
- Tirol, Kufstein, A.ö. Bezirkskrankenhaus Kufstein, Innere Medizin / Hämatologie / Onkologie
Trials:- NCT06250465 (Principal Investigator)
Conditions: -
Bernd Hartmann, MDSeen in:
- Feldkirch, LKH Feldkirch, Innere Medizin II, Interne E: Hämatologie und Onkologie
- Feldkirch, Landeskrankenhaus Feldkirch, Innere Med. II, Interne E
- Rankweil, LKH Feldkirch, Innere Medizin II, Interne E: Hämatologie und Onkologie
- Vorarlberg, Feldkirch, Landeskrankenhaus Feldkirch, Innere Med. II, Interne E
Trials:- NCT04891809 (Principal Investigator)
- NCT04438889 (Principal Investigator)
- NCT06250465 (Principal Investigator)
-
Clemens Schmitt, MDSeen in:
- Linz, KUK Linz: Klinik für Interne 3 - Schwerpunkt Hämatologie und Onkologie
- Linz, Kepler Universitatsklinikum, Med Campus III. Clinic of Internal Medicine 3 - Hematology and Oncology
- Linz, Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie
Trials:- NCT04910685 (Principal Investigator)
- NCT04438889 (Principal Investigator)
- NCT06250465 (Principal Investigator)
-
Daniel HeintelSeen in:
- Vienna, Klinik Ottakring
Trials:- NCT05023980 (Principal Investigator)
Conditions: -
Dominik Wolf, MDSeen in:
- Innsbruck, Univ.-Klinik für Innere Medizin V, Hämatologie/Onkologie LKH-Innsbruck / Universitätskliniken
- Tirol, Innsbruck, Univ.-Klinik für Innere Medizin V, Hämatologie/Onkologie LKH-Innsbruck / Universitätskliniken
Trials:- NCT06250465 (Principal Investigator)
Conditions: -
Manuel OrlingerSeen in:
- Linz, Krankenhaus Barmherzige Schwestern Linz
- Linz, Ordensklinikum Linz GmbH - Barmherzige Schwestern; Interne I: Medizinische Onkologie und Hämatologie
- Oberösterreich, Linz, Ordensklinikum Linz
- Oberösterreich, Linz, Ordensklinikum Linz GmbH - Barmherzige Schwestern; Interne I: Medizinische Onkologie und Hämatologie
Trials:- NCT05254743 (Principal Investigator)
- NCT06250465 (Principal Investigator)
-
Michael GirschikofskySeen in:
- Linz, Ordensklinikum Linz GmbH Elisabethinen
- Oberösterreich, Linz, Ordensklinikum Linz GmbH Elisabethinen
Trials:- NCT04666038 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Petra Pichler, MDSeen in:
- St. Pölten, Universitätsklinikum St. Pölten, Klinische Abteilung für Innere Medizin 1
- St.Pölten, Univ.-Klinikum St. Pölten, Innere Medizin 1
Trials:- NCT04891809 (Principal Investigator)
- NCT04438889 (Principal Investigator)
- NCT06250465 (Principal Investigator)
-
Philipp StaberSeen in:
- Wien, Medizinische Universität Wien
Trials:- NCT04666038 (Principal Investigator)
Conditions: -
Richard Greil, MDSeen in:
- Salzburg, UK Salzburg, LKH: Universitätsklinik für Innere Medizin III
- Salzburg, Universitätsklinik für Innere Med. III, PMU Salzburg
- Salzburg, Universitätsklinik für Innere Medizin III, PMU Salzburg
Trials:- NCT04438889 (Principal Investigator)
- NCT04654364 (Principal Investigator)
- NCT06250465 (Principal Investigator)
- NCT06294652 (Principal Investigator)
-
Thomas BAUER, MDSeen in:
- Linz, Ordensklinikum Linz GmbH, Elisabethinen, I. Interne Abteilung Hämato-Onkologie
Trials:- NCT06250465 (Principal Investigator)
Conditions: -
Thomas NösslingerSeen in:
- Vienna, Hanusch Krankenhaus
Trials:- NCT05254743 (Principal Investigator)
Clinical Trials on Leukemia, Lymphocytic, Chronic, B-Cell
-
National Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingLeukemia, Lymphocytic, Chronic, B-Cell | Chronic Lymphocytic Leukemia | Leukemia, Chronic Lymphatic | B-Cell Chronic Lymphocytic Leukemia | Leukemia, Lymphocytic, Chronic | B-Lymphocytic Leukemia, Chronic | Leukemia, Chronic Lymphocytic, B-Cell | Lymphocytic Leukemia, Chronic, B Cell | Lymphocytic Leukemia...United States
-
Fred Hutchinson Cancer Research Center/University...WithdrawnB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia
-
National Cancer Institute (NCI)CompletedB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
French Innovative Leukemia OrganisationTerminatedB-cell Chronic Lymphocytic Leukemia (B-CLL)France
-
Genzyme, a Sanofi CompanyBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedB-Cell Chronic Lymphocytic Leukemia (B-CLL)United Kingdom, Belgium, France, United States, Czech Republic, Serbia
-
CelgeneCompletedB-cell Chronic Lymphocytic LeukemiaUnited States, Spain, United Kingdom, Canada, Belgium, Czechia, Hungary, Italy, Poland, Israel, Germany, Ireland, France, New Zealand, Denmark, Australia, Netherlands, Romania, Russian Federation, Sweden, Austria, South Africa, Colo... and more
-
French Innovative Leukemia OrganisationRoche Pharma AGCompletedB-cell Chronic Lymphocytic Leukemia CLLFrance
-
OnxeoCompletedB-cell Chronic Lymphocytic LeukemiaUnited Kingdom
-
AbbottGenentech, Inc.Withdrawn
-
Shanghai Zhangjiang Biotechnology Limited CompanySuspendedB-cell Chronic Lymphocytic LeukemiaChina